Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia - PubMed (original) (raw)
Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia
E D Janus et al. Eur J Clin Invest. 1980 Apr.
Abstract
Autologous 131I-labelled very low density lipoprotein (VLDL) and 125I-labelled low density lipoprotein (LDL) were injected into seven normal subjects and twenty-eight genetically classified hyperlipidaemic patients to quantitate lipoprotein interconversion. The apoprotein B specific activity--time curves for VLDl and intermediate density lipoprotein (IDL, density = 1 . 006--1 . 019 g/ml) intersected at or before the IDL-B maximum in thirty-one studies (five normal controls and twenty-six hyperlipidaemic subjects) implying that all IDL-B may be derived from VLDL-B. The fractional conversion of VLDL-B to LDL-B (density 1 . 019--1 . 063 g/ml) following a simultaneous spike injection of 131I-VLDL and 125-LDL was obtained by deconvolution of the 125I and 131I-LDL-B activity curves. 21--65% (mean = 44%) of VLDL-B was converted to LDL-B in twenty-three subjects studied. The mean conversion time ranged from 10 to 24 h in ten normotriglyceridaemic subjects and from 19 to 42 h (mean = 33 h) in twelve hypertriglyceridaemic subjects. In one patient with broad-beta disease the mean conversion time was 55 h. LDL-B production from VLDL-B and total LDL-B synthetic rate were essentially equal in normal controls and normocholesterolaemic subjects and in the patient with broad-beta disease. But in all six patients with familial hypercholesterolaemia LDL-B synthetic rate significantly exceeded LDL-B production from VLDL-B, indicating direct secretion of 20--72% of LDL-B at a rate which correlates positively with plasma LDL concentration. Three of five patients with familial combined hyperlipidaemia showed a lesser but nevertheless significant direct secretion of LDL-B.
Similar articles
- Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects.
Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B. Janus ED, et al. Eur J Clin Invest. 1980 Apr;10(2 Pt 1):161-72. doi: 10.1111/j.1365-2362.1980.tb02076.x. Eur J Clin Invest. 1980. PMID: 6780364 - Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
Sigurdsson G, Nicoll A, Lewis B. Sigurdsson G, et al. J Clin Invest. 1975 Dec;56(6):1481-90. doi: 10.1172/JCI108229. J Clin Invest. 1975. PMID: 172533 Free PMC article. - Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease.
Grundy SM, Vega GL, Kesäniemi YA. Grundy SM, et al. Acta Med Scand Suppl. 1985;701:23-37. doi: 10.1111/j.0954-6820.1985.tb08887.x. Acta Med Scand Suppl. 1985. PMID: 3907293 Review. - Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E.
Weisgraber KH, Innerarity TL, Rall SC Jr, Mahley RW. Weisgraber KH, et al. Ann N Y Acad Sci. 1990;598:37-48. doi: 10.1111/j.1749-6632.1990.tb42274.x. Ann N Y Acad Sci. 1990. PMID: 2248450 Review.
Cited by
- Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.
Strong A, Ding Q, Edmondson AC, Millar JS, Sachs KV, Li X, Kumaravel A, Wang MY, Ai D, Guo L, Alexander ET, Nguyen D, Lund-Katz S, Phillips MC, Morales CR, Tall AR, Kathiresan S, Fisher EA, Musunuru K, Rader DJ. Strong A, et al. J Clin Invest. 2012 Aug;122(8):2807-16. doi: 10.1172/JCI63563. Epub 2012 Jul 2. J Clin Invest. 2012. PMID: 22751103 Free PMC article. - Genes and nutrition in the regulation of human lipoprotein metabolism.
Lewis B. Lewis B. Klin Wochenschr. 1981 Sep 15;59(18):1037-42. doi: 10.1007/BF01747746. Klin Wochenschr. 1981. PMID: 7300232 No abstract available. - Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.
Turner PR, Miller NE, Cortese C, Hazzard W, Coltart J, Lewis B. Turner PR, et al. J Clin Invest. 1981 Jun;67(6):1678-86. doi: 10.1172/jci110205. J Clin Invest. 1981. PMID: 7240415 Free PMC article. - Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.
Kesaniemi YA, Grundy SM. Kesaniemi YA, et al. J Clin Invest. 1982 Jul;70(1):13-22. doi: 10.1172/jci110585. J Clin Invest. 1982. PMID: 7085881 Free PMC article. - Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.
Miller NE, Hammett F, Saltissi S, Rao S, van Zeller H, Coltart J, Lewis B. Miller NE, et al. Br Med J (Clin Res Ed). 1981 May 30;282(6278):1741-4. doi: 10.1136/bmj.282.6278.1741. Br Med J (Clin Res Ed). 1981. PMID: 6786600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources